Prilly Pharmaceuticals Private Limited - Due diligence report

A 360° intelligence report on Prilly Pharmaceuticals Private Limited: trust score, financial health, credit view, compliance, directors, gro…

2023-06-27 Gmc, Assam Active Unlisted
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Prilly Pharmaceuticals Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
82/100
Trust Score
Low Risk

Prilly Pharmaceuticals Private Limited is assessed as Low Risk with a Trust Score of 82/100. Prilly Pharmaceuticals Private Limited is an active private limited indian non-government company incorporated in 2023. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and an unassessed financial risk profile.

Report generated on 16 Oct 2026 from the latest processed filings. Prilly Pharmaceuticals Private Limited snapshot & full profile →

Financial Health › No Data
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
82/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreNo Data
N/A
No processed financial statements available yet.
Credit Risk ScoreNo Data
N/A
Financial statements needed for a credit view.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

No processed financials
Financial statements are not yet processed for this company. Trend analysis will appear once filings are available.
04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: N/A No Data
  • Financial statements needed for a credit view.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
JAY DEEP GHOSH 01234567 Director 01/04/2018 6 yrs Approved
VARUN CHHAWCHHARIA 01234567 Director 01/04/2018 6 yrs Approved
RITUPARNA SINHA 01234567 Director 01/04/2018 6 yrs Approved
Suvam Dey Sarkar 01234567 Director 01/04/2018 6 yrs Approved
Nayan Jyoti Das 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 90
Growth signals & trust indicators
Young company (3 years).
Financials unavailable - score leans on compliance and governance signals.
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence87/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • No financials on record - ask for audited statements.
Banker assessment71/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • No filed financials - rely on banking statements and GST data.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view62/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Request management accounts - public filings insufficient.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 9 events
29 Jul 2025
Last AGM held
Annual general meeting
30 Apr 2025
Director appointed
Suvam Dey Sarkar (Additional Director)
Director appointed
Nayan Jyoti Das (Additional Director)
Director ceased
Sapna Brahma
31 Mar 2025
Latest balance sheet
Filed with ROC
27 Jun 2023
Incorporated
Registered with Roc Guwahati
Director appointed
JAY DEEP GHOSH (Director)
Director appointed
VARUN CHHAWCHHARIA (Director)
Director appointed
RITUPARNA SINHA (Director)
10

Key Observations

Auto-generated from the data above
Compliance record is strong - status, filings and flags are clean.
5 active director(s) / partner(s); board looks stable and experienced.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
AR IVF LLP AAY-6407 Kamrup, Assam
Bishal Projects & Services Limited U70101AS2009PLC009224 Kamrup, Assam
Axom Marketing & Services Private Limited U51399AS2015PTC012215 Kamrup, Assam
Master (India) Brewing Company Private Limited U15511AS1999PTC005915 Kamrup, Assam
Sanyam Pharmaceuticals Private Limited U51909AS2018PTC018765 Kamrup, Assam
SRIMANTA SANKARDEV ELECTRONICS LLP AAP-3140 Kamrup, Assam
Ks2 Innovation & Technology Private Limited U72900AS2022PTC022749 Kamrup, Assam
Shinycarz Services Private Limited U34300AS2019PTC019602 Kamrup, Assam
Nezone Medicines Private Limited U24232AS2002PTC006795 Kamrup, Assam
KEYMAN SOLUTION LLP AAO-6254 Kamrup, Assam
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Prilly Pharmaceuticals Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Prilly Pharmaceuticals Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Prilly Pharmaceuticals Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 82/100, distress signals and MSME payment-delay disclosures - know whether Prilly Pharmaceuticals Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Prilly Pharmaceuticals Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Prilly Pharmaceuticals Private Limited an active company?

Prilly Pharmaceuticals Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Prilly Pharmaceuticals Private Limited financially healthy?

Processed financial statements are not yet available for Prilly Pharmaceuticals Private Limited, so its financial health is unassessed.

Should I do business with Prilly Pharmaceuticals Private Limited?

Its overall Trust Score is 82/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Prilly Pharmaceuticals Private Limited?

See the directors and ownership sections above for board and shareholding detail. 5 active director(s) are on record.

Does Prilly Pharmaceuticals Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Prilly Pharmaceuticals Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Prilly Pharmaceuticals Private Limited?

Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.